124 related articles for article (PubMed ID: 38594829)
1. p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
Becker AS; Merkel J; Bozkurt I; Strüder DF; Maletzki C; Hühns M; Zimpfer AH
Head Neck; 2024 Apr; ():. PubMed ID: 38594829
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
[TBL] [Abstract][Full Text] [Related]
5. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.
Holzinger D; Flechtenmacher C; Henfling N; Kaden I; Grabe N; Lahrmann B; Schmitt M; Hess J; Pawlita M; Bosch FX
Int J Cancer; 2013 Sep; 133(6):1389-99. PubMed ID: 23457055
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
8. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
[TBL] [Abstract][Full Text] [Related]
9. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
[TBL] [Abstract][Full Text] [Related]
10. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Evaluation of p16 and p53 in Oral and Oropharyngeal Squamous Cell Carcinoma with Special Regard to Human Papillomavirus Status.
Ghosh U; Tripathy R; Lenka A; Turuk J; Mohapatra D
J Microsc Ultrastruct; 2023; 11(3):172-178. PubMed ID: 38025188
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Diagnosis.
Perera PY; Perera LP; Filkoski L; Chen W; Lichy JH; Paal E; Maxwell JH
World J Oncol; 2020 Feb; 11(1):1-8. PubMed ID: 32095184
[TBL] [Abstract][Full Text] [Related]
14. The Role of the p16 and p53 Tumor Suppressor Proteins and Viral HPV16 E6 and E7 Oncoproteins in the Assessment of Survival in Patients with Head and Neck Cancers Associated with Human Papillomavirus Infections.
Lifsics A; Cistjakovs M; Sokolovska L; Deksnis R; Murovska M; Groma V
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345059
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization.
Pannone G; Rodolico V; Santoro A; Lo Muzio L; Franco R; Botti G; Aquino G; Pedicillo MC; Cagiano S; Campisi G; Rubini C; Papagerakis S; De Rosa G; Tornesello ML; Buonaguro FM; Staibano S; Bufo P
Infect Agent Cancer; 2012 Feb; 7():4. PubMed ID: 22376902
[TBL] [Abstract][Full Text] [Related]
16. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus and oral and oropharyngeal carcinoma: the essentials.
Yakin M; Seo B; Hussaini H; Rich A; Hunter K
Aust Dent J; 2019 Mar; 64(1):11-18. PubMed ID: 30238467
[TBL] [Abstract][Full Text] [Related]
18. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
[TBL] [Abstract][Full Text] [Related]
20. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
